"We need to focus on getting these drugs to patients quickly," expert says ...

Researchers conducted a retrospective cross-sectional analysis of patients diagnosed with de novo metastatic breast cancer to evaluate presentation and treatment differences across three main subtypes ...

Before my daughter was diagnosed with breast cancer, the “M” word was not a part of my vocabulary.

FDA accepted an RTOR sBLA and granted priority review for zanidatamab-hrii combinations as first-line therapy in HER2+ ...

Daraxonrasib delivered a median overall survival of 13.2 months versus 6.7 months with standard chemotherapy in previously ...

Magnitude and Temporal Variations of Socioeconomic Inequalities in the Quality of Life After Early Breast Cancer: Results From the Multicentric French CANTO Cohort In patients with pMMR or not MSI-H ...

How to know when it's time to get checked, brought to you by the editors of Verywell Health ljubaphoto / Getty Images Metastatic breast cancer occurs when breast cancer cells move into other parts of ...

Zanidatamab plus chemotherapy with or without tislelizumab significantly improves progression free survival in first-line ...

First-time seizures were associated with a higher risk of neurologic and non-neurologic cancers within 1 year and beyond, a ...

Get the facts about metastasis, as well as learn about some of the myths about the condition, from the editors of PEOPLE and Verywell Health Getty If you’ve been diagnosed with early-stage breast ...

Studies will showcase the ultrasensitive structural variant-based detection of ctDNA in metastatic breast cancer and ...

Understanding which cells within a tumor will go on to form metastases remains one of the major challenges in cancer research ...